Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Blodtrykssænkende strategier for at eliminere hypertensionsforskelle (VELsignet) (BLESSED)

28. september 2026 opdateret af: Jiang He, MD, PhD, Tulane University

Blodtrykssænkende strategier for at eliminere hypertensionsforskelle

The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test the effectiveness, implementation, and sustainability of a community health worker (CHW)-led multifaceted intervention compared to enhanced usual care for hypertension control in Black communities. In the BLESSED trial, the investigators plan to recruit 1,176 adults with hypertension (approximately 28 per church) from 42 predominantly Black churches in the Greater New Orleans area. The multifaceted intervention will last for 18 months, followed by a post-intervention follow-up visit at 24 months. The BLESSED trial aims to generate evidence regarding the effectiveness, implementation, and sustainability of this CHW-led church-based multifaceted intervention in eliminating hypertension disparities in the United States (US) general population.

Studieoversigt

Detaljeret beskrivelse

Louisiana residents, especially African Americans, bear a disproportionately high burden of hypertension and cardiovascular disease (CVD). In the Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial, the investigators will compare the impact of two implementation strategies - a CHW-led multifaceted strategy and a group-based education strategy - for delivering interventions recommended by the 2017 American College of Cardiology (ACC) and the American Heart Association (AHA) hypertension clinical guidelines on implementation and clinical effectiveness outcomes in predominantly Black community members over 18 months. The BLESSED study utilizes an effectiveness-implementation hybrid design to: (1). test the effectiveness of a CHW-led church-based multifaceted implementation strategy for reducing estimated CVD risk over 18 months among African American church community members at high risk for CVD, and (2). assess the implementation outcomes (acceptability, adaptation, adoption, feasibility, fidelity, penetrance, cost-effectiveness, and sustainability) simultaneously. The Exploration, Preparation, Implementation, Sustainment (EPIS) framework has guided the development and evaluation of the multifaceted implementation strategy, which includes CHW-led health coaching on lifestyle changes and medication adherence; healthcare delivery in community; church-based exercise and weight loss programs; self-monitoring of blood pressure (BP); and provider education and engagement. The CHW-led church-based intervention will provide strong social support and tackle multiple social determinants of CVD disparities. The primary clinical effectiveness outcome is the difference in mean change of systolic blood pressure (SBP) from baseline to 18 months between intervention and control groups. The primary implementation outcome is a fidelity summary score for key implementation strategy components to the CHW-led church-based multifaceted implementation strategy assessed at the participant levels. This study has 90% statistical power to detect group differences in mean SBP change of 5.8 mm Hg over 18 months using a 2-sided significance level of 0.05. The investigators will recruit 1,176 participants (28 per church) who are aged ≥18 years with systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg, and randomly assign 21 churches to intervention and 21 to control; the investigators will implement the multifaceted intervention program; the investigators will follow-up participants and collect data on effectiveness and implementation outcomes at 6, 12, and 18 months; the investigators will evaluate the sustainability of the intervention at 6 months post-intervention; and the investigators will perform intention-to-treat analyses and disseminate and scale-up the proven-effective implementation strategy. The proposed study will generate evidence on the effectiveness, implementation, and sustainability of the multifaceted intervention aimed at eliminating CVD disparities in African American populations in the US.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

1176

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Louisiana
      • New Orleans, Louisiana, Forenede Stater, 70112
        • Rekruttering
        • Tulane University
        • Kontakt:
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Men or women aged ≥18 years
  2. Community members associated with the participating churches (church members and their families and friends)
  3. Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg
  4. Willing and able to participate in the intervention.
  5. Willing and able to sign written informed consent.

Exclusion Criteria:

  1. Prior hospitalization in the last 3 months for chronic heart failure or heart attack
  2. Current diagnosis of cancer requiring chemotherapy or radiation therapy
  3. Stage-5 chronic kidney disease requiring chronic dialysis or transplant
  4. Pregnant or planning to become pregnant in the next 18 months
  5. Planning to move out of the Greater New Orleans area during the next year

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Community health worker-led implementation strategy

CHW-led church-based multifaceted implementation strategy: CHWs will conduct individualized health coaching and healthcare navigation, organize church-based health promotion programs (e.g., nutrition education and exercise sessions), and train and assist the study participants in self-monitoring of BP. Nurse practitioners will see study participants at church settings, and community pharmacies will deliver antihypertensive medications to patients' homes.

The recommended evidence-based interventions include therapeutic lifestyle change and medical treatment of hypertension

Eksperimentel: Group-based Education Strategy

The investigator team will work with church leadership and wellness coordinators to organize group-based education sessions. Health education will be delivered by local primary care providers, dieticians, and health educators. Contact information for primary care providers and information on self-monitoring of BP will also be given at group sessions.

The recommended evidence-based interventions include therapeutic lifestyle change and medical treatment of hypertension

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Difference in mean change of systolic blood pressure
Tidsramme: Measured from baseline to 18 months

Difference in mean change of systolic blood pressure from baseline to 18 months between intervention and control groups

Measured from baseline to 18 months
Implementation fidelity summary score
Tidsramme: Measured at 6, 12, and 18 months

The fidelity summary score is composed of the following key implementation strategy components: proportion of assigned health education sessions attended in all participants, proportion of assigned discussion sessions attended in all participants, proportion of recommended minutes of physical activity completed in all participants, proportion of days per week that fruits/vegetables are eaten as recommended in all participants, proportion of recommended home blood pressure (BP) monitoring completed in patients with hypertension, proportion of required provider visits attended in all patients, and proportion of antihypertensive medications taken in patients with hypertension. The score ranged from zero to six with a higher score indicates greater fidelity.

Measured at 6, 12, and 18 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Difference in the proportion of patients with controlled BP between intervention and control groups
Tidsramme: Measured from baseline to 18 months

Difference in the proportion of patients with controlled BP (<130/80 mm Hg) between intervention and control groups at 18 months

Measured from baseline to 18 months
Difference in mean change of diastolic BP
Tidsramme: Measured from baseline to 18 months

Difference in mean change of diastolic BP (DBP) from baseline to 18 months between intervention and control groups

Measured from baseline to 18 months
Side effects of medications and adverse events
Tidsramme: Measured from baseline to 18 months

Change in side effects of medications and adverse events from baseline to 18 months

Measured from baseline to 18 months
Cost-effectiveness
Tidsramme: Measured from baseline to 18 months

Cost-effectiveness assessed as incremental direct costs per additional percentage of hypertension control

Measured from baseline to 18 months
Acceptability
Tidsramme: Measured from baseline to 18 months

Percentage of participants, community health worker, providers, and church administrators who reply that the intervention is acceptable (satisfactory). Measured by survey.

Measured from baseline to 18 months
Adoption (Churches)
Tidsramme: Measured from baseline to 18 months

% of churches adopting the intervention program

Measured from baseline to 18 months
Adoption (Providers)
Tidsramme: Measured from baseline to 18 months

% of invited providers attending training sessions

Measured from baseline to 18 months
Appropriateness
Tidsramme: Measured from baseline to 18 months

Percentage of participants, community health workers, providers, and church administrators who reply that the intervention is appropriate (good perceived fit). The outcome will be measured by survey question.

Measured from baseline to 18 months
Feasibility to participant, community health worker, provider and churches
Tidsramme: Measured from baseline to 18 months

Percentage of participants, community health worker, providers, and church administrators who reply that the intervention is feasible (actual fit, suitability). Measured by survey and study administrative data.

Measured from baseline to 18 months
Exercise Session Fidelity (community health worker-led strategy group)
Tidsramme: Measured at 6, 12, and 18 months

Percentage of exercise sessions organized. Measured by study administrative data.

Measured at 6, 12, and 18 months
Fidelity of Group Health Education Session
Tidsramme: Measured at 6, 12, and 18 months

Percentage of group health education sessions conducted out of health educated sessions planned per study protocol.

Measured at 6, 12, and 18 months
Nutrition Education Session Fidelity (community health worker-led strategy group)
Tidsramme: Measured at 6, 12, and 18 months

Percentage of nutrition education sessions organized. Measured by study administrative data.

Measured at 6, 12, and 18 months
Health Care Appointment Fidelity (community health worker-led strategy group)
Tidsramme: Measured at 6, 12, and 18 months

Percentage of health care visit appointments made. Measured by study administrative data.

Measured at 6, 12, and 18 months
Percentage of enrolled participants receiving assigned intervention. Measured by study administrative data. Reach (Participants)
Tidsramme: Measured at baseline, 6, 12, and 18 months

Percentage of enrolled participants receiving assigned intervention. Measured by study administrative data.

Measured at baseline, 6, 12, and 18 months
Reach (Participants)
Tidsramme: Measured at baseline

The percentage of eligible/screened/contacted participants enrolled. Measured by study data, administrative data.

Measured at baseline
Penetrance (Participants)
Tidsramme: Measured at baseline, 6, 12, and 18 months

Percentage of enrolled participants receiving assigned intervention. Measured by intervention monitoring data.

Measured at baseline, 6, 12, and 18 months
Penetrance (Providers)
Tidsramme: Measured at baseline, 6, 12, and 18 months

Percentage of trained providers delivering protocol-based care. Measured by intervention monitoring data.

Measured at baseline, 6, 12, and 18 months
Penetrance (educators)
Tidsramme: Measured at baseline, 6, 12, and 18 months

Percentage of trained CHWs or providers and health educators delivering health coaching. Measured by intervention monitoring data.

Measured at baseline, 6, 12, and 18 months
Sustainability (Churches)
Tidsramme: Measured at baseline, 6, 12, and 18 months

Percentage of churches continuing the intervention program and individual components. Measured by 6-month post-intervention survey.

Measured at baseline, 6, 12, and 18 months
Sustainability (Participants)
Tidsramme: Measured at 24 months

Percentage of participants maintaining ideal cardiovascular health metrics, healthy lifestyle components, and adherence to medications. Measured by 6-month post-intervention survey and examination.

Measured at 24 months
Sustainability Effectiveness Outcome: Differences in mean change of SBP and DBP
Tidsramme: Measured at baseline and 24 months

Differences in mean change of SBP and DBP from baseline to 24 months (6 months post-intervention) between intervention and control groups

Measured at baseline and 24 months
Sustainability Effectiveness Outcome: Difference in the proportion of patients with controlled BP
Tidsramme: Measured at baseline and 24 months

Difference in the proportion of patients with controlled BP (<130/80 mm Hg) between intervention and control groups at 24 months.

Measured at baseline and 24 months
Sustainability of Fidelity
Tidsramme: Measured at 24 months

A fidelity summary score for key implementation strategy components at 6 months post-intervention (24 months overall). The fidelity summary score is composed of the following key implementation strategy components: proportion of assigned health education sessions attended in all participants, proportion of assigned discussion sessions attended in all participants, proportion of recommended minutes of physical activity completed in all participants, proportion of days per week that fruits/vegetables are eaten as recommended in all participants, proportion of recommended home BP monitoring completed in patients with hypertension, proportion of required provider visits attended in all patients, and proportion of antihypertensive medications taken in patients with hypertension. Fidelity score ranges from zero to six with a higher score indicates greater fidelity.

Measured at 24 months

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in quality of life
Tidsramme: Measured from baseline to 18 months

The difference in QoL between the two arms over 18 months. QoL will be assessed using the SF-12 questionnaire. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.

Measured from baseline to 18 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2023

Primær færdiggørelse (Anslået)

30. juni 2027

Studieafslutning (Anslået)

30. juni 2027

Datoer for studieregistrering

Først indsendt

1. november 2023

Først indsendt, der opfyldte QC-kriterier

10. november 2023

Først opslået (Faktiske)

15. november 2023

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

1. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

28. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 2022-1081-SPHTM
  • R01MD018193 (U.S. NIH-bevilling/kontrakt)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

The study data sharing plan will comply with all NIH policies for data sharing. Data sharing will be executed through the centralized NIH data repository and will be implemented in a timely manner. The study data, including data from baseline and follow-up visits, will be prepared for transmission to the NHLBI data repository - the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). The datasets will be submitted to the NHLBI no later than three years after the end of the final participant follow-up or two years after the main paper of the trial has been published, whichever comes first. The NHLBI will review the submitted data prior to release. These data will be free of identifiers that allow identification of individual research participants either directly or through "deductive disclosure." In addition, the investigators will offer, through a publicly accessible website, opportunities for outside investigators to collaborate using complete study data.

IPD-delingstidsramme

No later than three years after the end of the final participant follow-up or two years after the main paper of the trial has been published, whichever comes first

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner